Tuesday 03/28/2017 07:05 AM ET - PR Newswire via Dow Jones News
Biostage to present in the 3D Printing and BioEngineering panel on Thursday, March 30 at 2:30 PM ET HOLLISTON, Mass., March 28, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, today announced that Jim McGorry, CEO of Biostage, will present on the 3D Printing and BioEngineering panel at the MassBio 2017 Annual Meeting on Thursday, March 30, 2017 at 2:30 PM ET in Cambrige, Massachussetts. The 3D Printing and BioEngineering panel will address the developments and discoveries in 3D printing in medicine and research, focusing on how advances in 3D printing are pushing the boundaries of medical innovation.
Recent HRGN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:47:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 07:04:40 PM
- Approval of Orphan Disease Application for this Biotech Firm • AllPennyStocks.com • 08/21/2023 03:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM